Asthma 2015: The Year in Review

References

1. 1.↵
   1. Ahangari F,
   2. Sood A,
   3. Ma B,
   4. Takyar S,
   5. Schuyler M,
   6. Qualls C,
   7. et al

   . Chitinase 3-like-1 regulates both visceral fat accumulation and asthma-like Th2 inflammation. Am J Respir Crit Care Med 2015;191(7):746–757.

   OpenUrlPubMed
2. 2.↵
   1. Lang JE,
   2. Hossain MJ,
   3. Lima JJ

   . Overweight children report qualitatively distinct asthma symptoms: analysis of validated symptom measures. J Allergy Clin Immunol 2015;135(4):886–893.e3.

   OpenUrlCrossRef
3. 3.↵
   1. Pakhale S,
   2. Baron J,
   3. Dent R,
   4. Vandemheen K,
   5. Aaron SD

   . Effects of weight loss on airway responsiveness in obese adults with asthma: does weight loss lead to reversibility of asthma? Chest 2015;147(6):1582–1590.

   OpenUrlPubMed
4. 4.↵
   1. Mackay D,
   2. Haw S,
   3. Ayres JG,
   4. Fischbacher C,
   5. Pell JP

   . Smoke-free legislation and hospitalizations for childhood asthma. N Engl J Med 2010;363(12):1139–1145.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Lin HC,
   2. Park JY,
   3. Seo DC

   . Comprehensive US statewide smoke-free indoor air legislation and secondhand smoke exposure, asthma prevalence, and related doctor visits: 2007-2011. Am J Public Health 2015;105(8):1617–1622.

   OpenUrlPubMed
6. 6.↵
   1. Bender BG,
   2. Cvietusa PJ,
   3. Goodrich GK,
   4. Lowe R,
   5. Nuanes HA,
   6. Rand C,
   7. Shetterly S,
   8. Tacinas C,
   9. Vollmer WM,
   10. Wagner N,
   11. Wamboldt FS,
   12. Xu S,
   13. Magid DJ

   . Pragmatic trial of health care technologies to improve adherence to pediatric asthma treatment: a randomized clinical trial. JAMA Pediatr 2015;169(4):317–323.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Auger KA,
   2. Kahn RS,
   3. Davis MM,
   4. Simmons JM

   . Pediatric asthma readmission: asthma knowledge is not enough? J Pediatr 2015;166(1):101–108.

   OpenUrlPubMed
8. 8.↵
   1. Rowe BH,
   2. Villa-Roel C,
   3. Majumdar SR,
   4. Abu-Laban RB,
   5. Aaron SD,
   6. Stiell IG,
   7. et al

   . Rates and correlates of relapse following ED discharge for acute asthma: a Canadian 20-site prospective cohort study. Chest 2015;147(1):140–149.

   OpenUrlPubMed
9. 9.↵
   1. Kenyon CC,
   2. Rubin DM,
   3. Zorc JJ,
   4. Mohamad Z,
   5. Faerber JA,
   6. Feudtner C

   . Childhood asthma hospital discharge medication fills and risk of subsequent readmission. J Pediatr 2015;166(5):1121–1127.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Sheares BJ,
    2. Mellins RB,
    3. Dimango E,
    4. Serebrisky D,
    5. Zhang Y,
    6. Bye MR,
    7. Dovey ME,
    8. Nachman S,
    9. Hutchinson V,
    10. Evans D

    . Do patients of subspecialist physicians benefit from written asthma action plans? Am J Respir Crit Care Med 2015;191(12):1374–1383.

    OpenUrlPubMed
11. 11.↵
    1. Cheelo M,
    2. Lodge CJ,
    3. Dharmage SC,
    4. Simpson JA,
    5. Matheson M,
    6. Heinrich J,
    7. Lowe AJ

    . Paracetamol exposure in pregnancy and early childhood and development of childhood asthma: a systematic review and meta-analysis. Arch Dis Child 2015;100(1):81–89.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Sordillo JE,
    2. Scirica CV,
    3. Rifas-Shiman SL,
    4. Gillman MW,
    5. Bunyavanich S,
    6. Camargo CA Jr.,
    7. et al

    . Prenatal and infant exposure to acetaminophen and ibuprofen and the risk for wheeze and asthma in children. J Allergy Clin Immunol 2015;135(2):441–448.

    OpenUrlCrossRef
13. 13.↵
    1. Namazy J,
    2. Cabana MD,
    3. Scheuerle AE,
    4. Thorp JM Jr..,
    5. Chen H,
    6. Carrigan G,
    7. et al

    . The Xolair pregnancy registry (EXPECT): the safety of omalizumab use during pregnancy. J Allergy Clin Immunol 2015;135(2):407–412.

    OpenUrl
14. 14.↵
    1. Eltonsy S,
    2. Forget A,
    3. Beauchesne MF,
    4. Blais L

    . Risk of congenital malformations for asthmatic pregnant women using a long acting beta agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy. J Allergy Clin Immunol 2015;135(1):123–130.

    OpenUrl
15. 15.↵
    1. Kelly W,
    2. Massoumi A,
    3. Lazarus A

    . Asthma in pregnancy: Physiology, diagnosis, and management. Postgrad Med 2015;127(4):349–358.

    OpenUrl
16. 16.↵
    1. Reddel HK

    . Treatment of overlapping asthma-chronic obstructive pulmonary disease: can guidelines contribute in an evidence-free zone? J Allergy Clin Immunol 2015;136(3):546–552.

    OpenUrlCrossRef
17. 17.↵
    1. Fingleton J,
    2. Travers J,
    3. Williams M,
    4. Charles T,
    5. Bowles D,
    6. Strik R,
    7. et al

    . Treatment responsiveness of phenotypes of symptomatic airways obstruction in adults. J Allergy Clin Immunol 2015;136(3):601–609.

    OpenUrlCrossRef
18. 18.↵
    1. Ghebre MA,
    2. Bafadhel M,
    3. Desai D,
    4. Cohen SE,
    5. Newbold P,
    6. Rapley L,
    7. et al

    . Biological clustering supports both “Dutch” and “British” hypotheses of asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol 2015;135(1):63–72.

    OpenUrlCrossRef
19. 19.↵
    1. Chung WS,
    2. Lin CL,
    3. Kao CH

    . Comparison of acute respiratory events between asthma-COPD overlap syndrome and COPD patients: a population-based cohort study. Medicine 2015;94(17):e755.

    OpenUrlPubMed
20. 20.↵
    1. Boulet LP,
    2. O'Byrne PM

    . Asthma and exercise-induced bronchoconstriction in athletes. N Engl J Med 2015;372(7):641–648.

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Daubresse M,
    2. Hutfless S,
    3. Kim Y,
    4. Kornfield R,
    5. Qato DM,
    6. Huang J,
    7. Miller K,
    8. Emery SL,
    9. Alexander GC

    . Effect of direct-to-consumer advertising on asthma medication sales and healthcare use. Am J Respir Crit Care Med 2015;192(1):40–46.

    OpenUrlPubMed
22. 22.↵
    1. Rajan JP,
    2. Wineinger NE,
    3. Stevenson DD,
    4. White AA

    . Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature. J Allergy Clin Immunol 2015;135(3):676–681.e1.

    OpenUrlCrossRef
23. 23.↵
    1. Jena AB,
    2. Ho O,
    3. Goldman DP,
    4. Karaca-Mandic P

    . The impact of the US Food and Drug Administration chlorofluorocarbon ban on out-of-pocket costs and use of albuterol inhalers among individuals with asthma. JAMA Intern Med 2015;175(7):1171–1179.

    OpenUrlPubMed